CME Group (NASDAQ:CME) Given New $212.00 Price Target at JPMorgan Chase & Co.

CME Group (NASDAQ:CME) had its price objective upped by JPMorgan Chase & Co. from $209.00 to $212.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has an “underweight” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price target points to a potential downside of 15.56% from the company’s previous close.

CME has been the subject of several other reports. Deutsche Bank Aktiengesellschaft decreased their price objective on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Oppenheimer increased their price target on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Piper Sandler boosted their price objective on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Morgan Stanley lifted their target price on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday, October 17th. Finally, Barclays increased their price target on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus price target of $231.07.

CME Group Stock Up 0.8 %

Shares of CME traded up $2.09 during mid-day trading on Thursday, reaching $251.05. The company’s stock had a trading volume of 528,308 shares, compared to its average volume of 1,839,613. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group has a 12-month low of $190.70 and a 12-month high of $253.53. The stock has a market cap of $90.47 billion, a PE ratio of 26.39, a price-to-earnings-growth ratio of 5.54 and a beta of 0.57. The company’s 50 day moving average is $235.74 and its 200 day moving average is $225.08.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.34% and a return on equity of 13.39%. Equities analysts anticipate that CME Group will post 10.18 EPS for the current fiscal year.

CME Group declared that its board has approved a stock repurchase plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Institutional Investors Weigh In On CME Group

Institutional investors and hedge funds have recently modified their holdings of the stock. Truvestments Capital LLC purchased a new stake in shares of CME Group during the third quarter valued at approximately $26,000. SJS Investment Consulting Inc. lifted its holdings in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after buying an additional 97 shares in the last quarter. Dunhill Financial LLC lifted its holdings in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after buying an additional 43 shares during the last quarter. Finally, Financial Life Planners acquired a new stake in shares of CME Group during the fourth quarter valued at about $32,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.